Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Investment Income (2016 - 2017)

Historic Non Operating Investment Income for Aytu Biopharma (AYTU) over the last 2 years, with Q2 2017 value amounting to $230936.0.

  • Aytu Biopharma's Non Operating Investment Income changed N/A to $230936.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $666581.0, marking a year-over-year change of. This contributed to the annual value of $61519.0 for FY2017, which is 9366.85% down from last year.
  • As of Q2 2017, Aytu Biopharma's Non Operating Investment Income stood at $230936.0.
  • Aytu Biopharma's Non Operating Investment Income's 5-year high stood at $360.0 billion during Q4 2016, with a 5-year trough of -$292455.0 in Q1 2017.